These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 8043909)

  • 1. Thrombinogenesis and its pharmacological modulation in atherosclerosis.
    Szczeklik A; Musiał J; Dropiński J; Krzanowski M; Królikowski W; Undas A; Swadźba J; Duplaga M; Bodzoń W
    J Physiol Pharmacol; 1994 Mar; 45(1):3-11. PubMed ID: 8043909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation in myocardial infarction and hypercholesterolemia: effects of aspirin.
    Szczeklik A
    Thromb Haemost; 1995 Jul; 74(1):77-80. PubMed ID: 8578530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
    Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients.
    Keularts IM; Béguin S; de Zwaan C; Hemker HC
    Thromb Haemost; 1998 Sep; 80(3):370-1. PubMed ID: 9759611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet and antithrombin therapies in the acute coronary syndromes.
    Alexander JH; Harrington RA
    Curr Opin Cardiol; 1997 Jul; 12(4):427-37. PubMed ID: 9263656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
    Buchanan MR; Brister SJ
    Wien Klin Wochenschr; 1999 Feb; 111(3):81-9. PubMed ID: 10093889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels.
    Musiał J; Undas A; Undas R; Brozek J; Szczeklik A
    Thromb Haemost; 2001 Feb; 85(2):221-5. PubMed ID: 11246536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
    Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.